TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CHRS

Coherus BioSciences Inc

Healthcare · Biotechnology

1.20$ -7.1% vs. previous close Closing price · As of: Sep 24, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Coherus BioSciences Inc (CHRS) with date, type and a link to the original document.

Filings CHRS
Date Type Filing Original
08/28/2026 Capital measure Form 424B5 filed with the SEC View document ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?